Investment Management of Virginia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$5.05M Sell
47,434
-148
-0.3% -$16K 0.96% 34
2022
Q4
$5.28M Buy
47,582
+33
+0.1% +$3.37K 1.03% 29
2022
Q3
$4.1M Sell
47,549
-6,810
-13% -$608K 0.89% 35
2022
Q2
$4.96M Sell
54,359
-21
-0% -$1.86K 1.02% 27
2022
Q1
$4.46M Buy
54,380
+865
+2% +$68.2K 0.78% 42
2021
Q4
$4.1M Buy
53,515
+390
+0.7% +$31.1K 0.66% 51
2021
Q3
$3.99M Buy
53,125
+263
+0.5% +$20K 0.77% 46
2021
Q2
$4.11M Sell
52,862
-2,023
-4% -$150K 0.79% 43
2021
Q1
$4.04M Buy
54,885
+12,280
+29% +$906K 0.81% 42
2020
Q4
$3.33M Buy
42,605
+399
+0.9% +$30.5K 0.72% 46
2020
Q3
$3.34M Sell
42,206
-2,282
-5% -$179K 0.83% 42
2020
Q2
$3.28M Buy
44,488
+1,326
+3% +$99.8K 0.82% 40
2020
Q1
$3.17M Sell
43,162
-1,748
-4% -$137K 0.96% 32
2019
Q4
$3.9M Sell
44,910
-262
-0.6% -$21.5K 0.89% 38
2019
Q3
$3.63M Buy
45,172
+427
+1% +$34.2K 0.89% 36
2019
Q2
$3.58M Sell
44,745
-43,933
-50% -$3.36M 0.86% 38
2019
Q1
$7.04M Buy
88,678
+44,156
+99% +$3.3M 0.83% 37
2018
Q4
$3.25M Sell
44,522
-14,235
-24% -$1M 0.84% 38
2018
Q3
$3.98M Sell
58,757
-436
-0.7% -$27.8K 0.84% 34
2018
Q2
$3.43M Buy
59,193
+357
+0.6% +$20.1K 0.76% 43
2018
Q1
$3.06M Buy
58,836
+1,484
+3% +$80.1K 0.71% 48
2017
Q4
$3.08M Buy
57,352
+15,276
+36% +$847K 0.73% 49
2017
Q3
$2.57M Sell
42,076
-266
-0.6% -$16.1K 0.6% 58
2017
Q2
$2.59M Buy
42,342
+235
+0.6% +$14.3K 0.62% 54
2017
Q1
$2.55M Sell
42,107
-722
-2% -$43.8K 0.63% 54
2016
Q4
$2.41M Buy
42,829
+1,468
+4% +$85.9K 0.57% 57
2016
Q3
$2.46M Sell
41,361
-319
-0.8% -$18.7K 0.6% 54
2016
Q2
$2.29M Buy
41,680
+1,127
+3% +$60K 0.59% 60
2016
Q1
$2.05M Buy
40,553
+20,753
+105% +$1.02M 0.54% 60
2015
Q4
$998K Buy
19,800
+760
+4% +$38.3K 0.27% 111
2015
Q3
$897K Buy
+19,040
New +$1.01M 0.24% 118
2014
Q2
Sell
-4,058
Closed -$219K 157
2014
Q1
$219K Buy
+4,058
New +$210K 0.04% 158

Other funds holding MRK

Investment Management of Virginia's MRK Position: Q1 2023 in Review

Investment Management of Virginia reduced its Merck (MRK) stake by 0.31% in Q1 2023, selling an estimated $16K and leaving 47,434 shares worth $5.05M. The position accounts for 0.96% of the portfolio, ranked #34.

Investment Management of Virginia first reported a position in MRK in Q1 2014 and has held it in 32 quarters since. The position peaked at $7.04M in Q1 2019. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Investment Management of Virginia held 47,434 shares of Merck worth $5.05M as of Q1 2023.
  • Investment Management of Virginia sold 148 Merck shares in Q1 2023, an estimated $16K.
  • Merck made up 0.96% of Investment Management of Virginia's portfolio in Q1 2023, its #34 holding.
  • Investment Management of Virginia first reported a position in Merck in Q1 2014 and has held it in 32 quarters since.
  • Investment Management of Virginia's Merck position peaked at $7.04M in Q1 2019.
  • 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.